Literature DB >> 1495762

Autosomal dominant congenital miosis with megalocornea.

F M Meire1, J W Delleman.   

Abstract

A family with AD congenital miosis is presented. The ocular symptoms were: megalocornea, iris translucency, microcoria with poor pupillary dilatation and goniodysgenesis with anterior insertion of the iris. This observation confirms that in congenital miosis abnormal development of the whole anterior eye segment may occur. The patients have an increased risk to develop glaucoma. If retinoscopy is impossible due to pin-point pupils, ultrasonic biometry to determine the axial length is recommended. An optical iridectomy could improve visual performance at low illumination; the complaints of photophobia, which are related to the iris translucency, persist.

Entities:  

Mesh:

Year:  1992        PMID: 1495762     DOI: 10.3109/13816819209087612

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  5 in total

1.  Genotypic and phenotypic heterogeneity in familial microcoria.

Authors:  F D Bremner; H Houlden; S E Smith
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Megalocornea. Clinical and genetic aspects.

Authors:  F M Meire
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Biometry in X linked megalocornea: pathognomonic findings.

Authors:  F M Meire; J W Delleman
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

Review 4.  Congenital Microcoria: Clinical Features and Molecular Genetics.

Authors:  Clémentine Angée; Brigitte Nedelec; Elisa Erjavec; Jean-Michel Rozet; Lucas Fares Taie
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

5.  Ultrabiomicroscopic-histopathologic correlations in individuals with autosomal dominant congenital microcoria: three-generation family report.

Authors:  Arturo Ramirez-Miranda; Juan M Paulin-Huerta; Eduardo Chavez-Mondragón; Gilberto Islas-de la Vega; Abelardo Rodriguez-Reyes
Journal:  Case Rep Ophthalmol       Date:  2011-05-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.